Biotech stars Schleifer and Yan­copou­los share $52M in 2017 com­pen­sa­tion, even though Re­gen­eron's share price swooned

Two of the best paid ex­ec­u­tives in bio­phar­ma have earned an­oth­er big set of com­pen­sa­tion pack­ages for 2017.

Re­gen­eron $REGN CEO Len Schleifer earned com­pen­sa­tion to­tal­ing $26.5 mil­lion for last year, a small step down from the $28.3 mil­lion picked up in 2016, ac­cord­ing to their new­ly filed proxy. And his co-founder at the com­pa­ny, George Yan­copou­los, was right be­hind him with $25.2 mil­lion in com­pen­sa­tion — $2.5 mil­lion less than in 2017.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER